This inventor holds 1 USPTO granted patent. Top assignee: Ranbaxy Laboratories, Inc.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Jagdish Arora: Innovator in Pharmaceutical Formulations
Introduction
Jagdish Arora is a notable inventor based in Chaudlgarh, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release formulations. His innovative work has led to the creation of a unique tablet composition that enhances the delivery of active ingredients.
Latest Patents
Jagdish Arora holds a patent for a "Modified release matrix formulation of cefaclor and cephalexin." This pharmaceutical composition is designed for controlled release and comprises cefaclor, cephalexin, or their pharmaceutically acceptable hydrates, salts, or esters as active ingredients. The formulation includes a mixture of hydrophilic polymers of varying viscosity grades, such as hydroxypropyl methylcellulose and hydroxypropyl cellulose. The composition is tailored to ensure that the active ingredient is released at a rate suitable for twice-daily administration to human subjects. The tablets may also feature a rapidly dissolving water-soluble polymeric film coat.
Career Highlights
Jagdish Arora is associated with Ranbaxy Laboratories, Inc., where he has been instrumental in advancing pharmaceutical formulations. His expertise in the field has contributed to the development of innovative products that meet the therapeutic needs of patients.
Collaborations
Throughout his career, Jagdish has collaborated with esteemed colleagues, including Girish Kumar Jain and Himadri Sen. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Jagdish Arora's contributions to pharmaceutical formulations exemplify the impact of innovation in healthcare. His work not only enhances the efficacy of medications but also improves patient compliance. His dedication to advancing pharmaceutical science is commendable and continues to inspire future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
